Altre lingue Genmab A/S

Azioni

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 16:59:56 26/04/2024			Variaz. 5gg	Var. 1 gen.
1.954 ^DKK	+2,04%		-2,01%	-9,30%

03/04	Genmab A/S conferma le previsioni di fatturato per l'anno 2024	CI
03/04	Transcript : Genmab A/S, ProfoundBio - M&A Call

Transactions in Connection with Share Buy-back Program Genmab	22/04
Transactions in Connection with Share Buy-back Program Genmab	22/04
Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	16/04
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024	16/04
Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	16/04
Transactions in Connection with Share Buy-back Program Genmab	15/04
Health Care Slips on Risk Bias -- Health Care Roundup	11/04
Transactions in Connection with Share Buy-back Program	08/04
AVIS D'ANALYSTES DU JOUR : BNP Paribas, Renault, Pernod-Ricard, Eurofins, Ferrari, Worldline, Sika, Elior...	04/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Adyen, Burberry, Endesa, Ferrari, Genmab, Melia Hotels, Telefónica, Sika..	04/04
Health Care Flat on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	03/04
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	03/04
ADC oncology acquisition to address solid tumours	03/04
Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...	03/04
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	03/04
Correction to Genmab Article	03/04
Genmab : l'acquisition de ProfoundBio accueillie sans émotion	03/04
News Highlights : Top Company News of the Day - Wednesday at 7 AM ET	03/04
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	03/04
European Midday Briefing : Stocks Continue to Struggle Despite Cooling Inflation	03/04

Non ci sono risultati per questa ricerca

GENMAB : Genmab è disponibile ad un prezzo vantaggioso

04 marzo 2024 alle 12:10

Genmab: una success story danese nel settore della salute